# Catalyst Bancorp, Inc.: financial statements, quarterly

CLST · Nasdaq · CIK 1849867 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/clst.md) · [Financials](/companies/clst/financials.md) · [Filings](/companies/clst/filings.md) · [Insiders](/companies/clst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [497](/filings/0001558370-23-018479.md) | [643 d](/filings/0001558370-24-004220.md) | [1,047](/filings/0001558370-24-008243.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [22.0](/filings/0001558370-24-015502.md) | [59.0 d](/filings/0001558370-25-003964.md) | [(1,267)](/filings/0001558370-25-007768.md) | [120](/filings/0001558370-25-011368.md) | [108](/filings/0001104659-25-111034.md) | [145 d](/filings/0001104659-26-037676.md) | [134](/filings/0001104659-26-062126.md) | [113](/filings/0001104659-26-096825.md) | [110](/filings/0001104659-25-111034.md) | [95.0 d](/filings/0001104659-26-037676.md) | [126](/filings/0001104659-26-062126.md) | [152](/filings/0001104659-26-096825.md) |
| Net income | $k | [151](/filings/0001558370-24-015502.md) | [307 d](/filings/0001558370-25-003964.md) | [(4,689)](/filings/0001558370-25-007768.md) | [527](/filings/0001558370-25-011368.md) | [447](/filings/0001104659-25-111034.md) | [626 d](/filings/0001104659-26-037676.md) | [586](/filings/0001104659-26-062126.md) | [521](/filings/0001104659-26-096825.md) | [489](/filings/0001104659-25-111034.md) | [456 d](/filings/0001104659-26-037676.md) | [558](/filings/0001104659-26-062126.md) | [524](/filings/0001104659-26-096825.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001558370-24-015502.md) | not reported | [(1.15)](/filings/0001558370-25-007768.md) | [0.13](/filings/0001558370-25-011368.md) | [0.11](/filings/0001104659-25-111034.md) | not reported | [0.16](/filings/0001104659-26-062126.md) | [0.14](/filings/0001104659-26-096825.md) | [0.13](/filings/0001104659-25-111034.md) | not reported | [0.15](/filings/0001104659-26-062126.md) | [0.14](/filings/0001104659-26-096825.md) |
| Basic EPS | $ per share | [0.03](/filings/0001558370-24-015502.md) | not reported | [(1.15)](/filings/0001558370-25-007768.md) | [0.13](/filings/0001558370-25-011368.md) | [0.11](/filings/0001104659-25-111034.md) | not reported | [0.16](/filings/0001104659-26-062126.md) | [0.14](/filings/0001104659-26-096825.md) | [0.13](/filings/0001104659-25-111034.md) | not reported | [0.16](/filings/0001104659-26-062126.md) | [0.15](/filings/0001104659-26-096825.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.3](/filings/0001558370-23-018479.md) | [19.0](/filings/0001558370-25-003964.md) | [76.0](/filings/0001558370-24-008243.md) | [75.5](/filings/0001558370-24-012040.md) | [45.8](/filings/0001558370-24-015502.md) | [44.3](/filings/0001104659-26-037676.md) | [40.3](/filings/0001558370-25-007768.md) | [40.1](/filings/0001558370-25-011368.md) | [37.3](/filings/0001104659-25-111034.md) | [25.2](/filings/0001104659-26-096825.md) | [38.5](/filings/0001104659-26-062126.md) | [37.0](/filings/0001104659-26-096825.md) |
| Total assets | $m | [258](/filings/0001558370-23-018479.md) | [271](/filings/0001558370-25-003964.md) | [282](/filings/0001558370-24-008243.md) | [295](/filings/0001558370-24-012040.md) | [281](/filings/0001558370-24-015502.md) | [277](/filings/0001104659-26-037676.md) | [272](/filings/0001558370-25-007768.md) | [274](/filings/0001558370-25-011368.md) | [284](/filings/0001104659-25-111034.md) | [283](/filings/0001104659-26-096825.md) | [289](/filings/0001104659-26-062126.md) | [290](/filings/0001104659-26-096825.md) |
| Total liabilities | $m | [176](/filings/0001558370-23-018479.md) | [186](/filings/0001558370-25-003964.md) | [201](/filings/0001558370-24-008243.md) | [214](/filings/0001558370-24-012040.md) | [199](/filings/0001558370-24-015502.md) | [196](/filings/0001104659-26-037676.md) | [191](/filings/0001558370-25-007768.md) | [193](/filings/0001558370-25-011368.md) | [202](/filings/0001104659-25-111034.md) | [201](/filings/0001104659-26-096825.md) | [206](/filings/0001104659-26-062126.md) | [207](/filings/0001104659-26-096825.md) |
| Long-term debt | $m | [9.3](/filings/0001558370-23-018479.md) | [19.4](/filings/0001558370-25-003964.md) | [29.4](/filings/0001558370-24-008243.md) | [30.3](/filings/0001558370-24-012040.md) | [29.5](/filings/0001558370-24-015502.md) | [9.6](/filings/0001104659-26-037676.md) | not reported | not reported | [14.7](/filings/0001104659-25-111034.md) | [14.7](/filings/0001104659-26-096825.md) | [9.8](/filings/0001104659-26-062126.md) | [9.8](/filings/0001104659-26-096825.md) |
| Shareholders' equity | $m | [82.2](/filings/0001558370-24-015502.md) | [84.6](/filings/0001104659-26-037676.md) | [81.3](/filings/0001558370-25-011368.md) | [81.0](/filings/0001104659-25-111034.md) | [81.7](/filings/0001104659-25-111034.md) | [80.2](/filings/0001104659-26-096825.md) | [80.6](/filings/0001104659-26-096825.md) | [80.8](/filings/0001104659-26-096825.md) | [81.6](/filings/0001104659-25-111034.md) | [81.7](/filings/0001104659-26-096825.md) | [82.2](/filings/0001104659-26-096825.md) | [82.5](/filings/0001104659-26-096825.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [540 d](/filings/0001558370-24-015502.md) | [930 d](/filings/0001558370-25-003964.md) | [247](/filings/0001558370-25-007768.md) | [1,393 d](/filings/0001558370-25-011368.md) | [896 d](/filings/0001104659-25-111034.md) | [636 d](/filings/0001104659-26-037676.md) | [427](/filings/0001104659-26-062126.md) | [1,151 d](/filings/0001104659-26-096825.md) | [912 d](/filings/0001104659-25-111034.md) | [797 d](/filings/0001104659-26-037676.md) | [661](/filings/0001104659-26-062126.md) | [958 d](/filings/0001104659-26-096825.md) |
| Capital expenditure | $k | [148 d](/filings/0001558370-24-015502.md) | [14.0 d](/filings/0001558370-25-003964.md) | [24.0](/filings/0001558370-25-007768.md) | [226 d](/filings/0001558370-25-011368.md) | [125 d](/filings/0001104659-25-111034.md) | [55.0 d](/filings/0001104659-26-037676.md) | [66.0](/filings/0001104659-26-062126.md) | [34.0 d](/filings/0001104659-26-096825.md) | [85.0 d](/filings/0001104659-25-111034.md) | [3.0 d](/filings/0001104659-26-037676.md) | [4.0](/filings/0001104659-26-062126.md) | [0.0 d](/filings/0001104659-26-096825.md) |
| Share repurchases | $k | [1,001 d](/filings/0001558370-24-015502.md) | [979 d](/filings/0001558370-25-003964.md) | [2,460](/filings/0001558370-25-007768.md) | [948 d](/filings/0001558370-25-011368.md) | [933 d](/filings/0001104659-25-111034.md) | [1,416 d](/filings/0001104659-26-037676.md) | [866](/filings/0001104659-26-062126.md) | [742 d](/filings/0001104659-26-096825.md) | [171 d](/filings/0001104659-25-111034.md) | [807 d](/filings/0001104659-26-037676.md) | [260](/filings/0001104659-26-062126.md) | [393 d](/filings/0001104659-26-096825.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,885](/filings/0001558370-23-018479.md) | [4,618](/filings/0001558370-24-008243.md) | [4,386](/filings/0001558370-24-012040.md) | [4,324](/filings/0001558370-24-015502.md) | [4,089](/filings/0001558370-25-007768.md) | [3,970](/filings/0001558370-25-011368.md) | [3,905](/filings/0001104659-25-111034.md) | [3,726](/filings/0001104659-26-062126.md) | [3,671](/filings/0001104659-26-096825.md) | [3,658](/filings/0001104659-25-111034.md) | [3,643](/filings/0001104659-26-062126.md) | [3,649](/filings/0001104659-26-096825.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,033,791 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-096825.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.